FDA Approved: PREGABALIN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for pregabalin filed by Chartwell RX, LLC (ANDA212865).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Partial-onset Seizures
• Postherpetic Neuralgia
• Spinal Cord Injury Neuropathic Pain

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)